Company profile
ADC Therapeutics SA Insider Trading
ADCTEvery SEC Form 4 insider trading filing for ADC Therapeutics SA (ADCT) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- NYSE
- Sector
- Pharmaceutical Preparations
- CIK
- 0001771910
- Filings
- 70
- Insiders
- 17
- Last filing
- 2026-06-30
Activity summary
No insider transactions in the last 30 days. The most recent was on June 30, 2026, when Ameet Mallik bought 675,000 shares. 70 filings from 17 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q1 24 to Q2 26. ADC Therapeutics SA insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $96.8M.
90 day insight
Over the last 90 days, ADC Therapeutics SA insiders bought $0 across 4 transactions with no open-market sales.
- Most active insider: Ameet Mallik with 1 transaction totaling $0.
Activity skews bullish: buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Ameet Mallik | ADCT | Award | 675,000 | — | — |
| Jun 30, 2026 | Peter J Graham | ADCT | Award | 221,100 | — | — |
| Jun 30, 2026 | Jose Carmona | ADCT | Award | 203,700 | — | — |
| Jun 30, 2026 | Mohamed Zaki | ADCT | Award | 213,900 | — | — |
| Jun 3, 2026 | Robert Azelby | ADCT | Tax Withholding | 12,600 | $3.08 | $39K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=ADCT" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.